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1078–5884/00Treatment of Primary Varicose Veins by Endovenous
Obliteration with the VNUS Closure System: Results of a
Prospective Multicentre Study
Ph. Nicolini* and The Closure Group1Vascular Surgery, Clinique du Grand Large, 2, avenue Le´on Blum, 69150 Decines Charpieu (Lyon), FranceBackground. Radio frequency obliteration of the saphenous veins has been introduced as a less invasive alternative to
traditional surgery for varicose veins.
Objective. To report the efficacy of obliteration and clinical outcomes following endovenous obliteration of the saphenous
vein with limited follow-up to 3 years
Materials and methods. Radiofrequency obliteration (Closurew system, VNUS Medical Technologies, San Jose, CA) was
performed in 330 limbs of 294 patients in a prospective worldwide multicentre study with 31 participating sites. Follow-up
duplex ultrasound and clinical examinations were performed at annual intervals. The main outcome measures were the
completeness of occlusion of the treated vein segment, presence of reflux and presence of signs and symptoms of venous
disease.
Results. Before treatment 3.9% of limbs were categorised as CEAP clinical class zero or one. This improved to 82.9% at 1
year, 83.1% at 2 years and 86.8% at 3 years following treatment. Varicose vein free rates were 1 year: 90.1%, 2 years: 87.2%,
3 years: 88.2%. Duplex ultrasound demonstrated a reflux-free rate of about 88% over 3 years. Total occlusion (TO) of veins
was 1 year: 81%, 2 years: 80.4% and 3 years: 75%. Partial occlusion (PO,!5 cm open segment) was 1 year: 6.3%, 2 years:
7.4% and 3 years: 17.6%. Incomplete occlusion (IO,O5 cm open segment) was 1 year: 12.7%, 2 years: 12.2% and 3 years:
7.4%. Partial occlusion did not result in any differences in the symptom severity score, the number of symptom free limbs, or
the varicose vein absence rates at any follow-up time point when compared to the total occlusion group. The varicose vein
absence rates were significantly lower in the IO group comparing to the TO and PO groups.
Conclusions. Radiofrequency saphenous vein obliteration improves the symptoms of varicose veins. The reflux-free rates in
the treated veins remain constant over a 3 year follow-up period. There is no difference in clinical outcomes between the TO
and the PO limbs, suggesting clinical effectiveness of the PO category. Greater than a 5 cm open segment in treated veins
poses a risk of recurrence.Keywords: Radiofrequency obliteration; Endovenous; Saphenous vein; Varicose veins.Introduction
Surgery has been used for more than a century in the
treatment of primary varicose veins of the lower limbs.
Surgical treatments are classified into two distinct
groups: resection surgery (e.g. saphenous vein strip-
ping) and conservative surgery, which leaves the
saphenous vein intact while eliminating the pathology.
These techniques have been joined by less invasive
endovascular techniques including radiofrequency
obliteration. In the latter technique radiofrequencying author. Ph. Nicolini, MD, Vascular Surgery,
Grand Large, 2, avenue Le´on Blum, 69150 Decines
on), France.
: phnicolini@wanadoo.fr
x attached.
0433+ 07 $35.00/0 q 2004 Elsevier Ltd. All rights reser(RF) energy is used to heat the vein causing thermal
destruction and vein shrinkage, with subsequent
fibrotic vein occlusion.
Earlier articles analysed findings from 1 to 2 year
clinical and duplex ultrasound follow-up.1–6 This
report presents limited 3 year results of endovenous
radiofrequency obliteration of saphenous vein reflux
and aims to examine the haemodynamic factors
influencing the clinical outcome.Materials and Methods
This multicentre study was conducted in both univer-
sity and state hospitals as well as in private practices.
The study was undertaken principally in Europe butEur J Vasc Endovasc Surg 29, 433–439 (2005)
doi:10.1016/j.ejvs.2004.12.022, available online at http://www.sciencedirect.com onved.
Ph. Nicolini and The Closure Group434also included centres in the United States and
Australia. The study was submitted to ethics
committees and, where applicable, to the local health
service authorities for approval. Patients who gave
informed written consent were included in the study.
Common ethics committee requirements are in force in
most of the countries involved.
Two hundred and ninety-four patients were
included in this study between December 1998 and
November 1999. In all, 330 limbs were treated for
primary varicose veins in this multicentre, non-
randomised, non-blinded prospective study. Female
patients formed 76.9% of the group and the overall
mean age was 46.3 years (range 18–97). A standardised
case report form (CRF) was used at all the participat-
ing centres, thereby ensuring uniformity of data
reporting. Study guidelines and standard protocols
were issued to achieve consistency between the
contributing centres. Clinical examination was always
done by the same investigator at each centre. When
possible, only one ultrasonographer at each centre was
involved. During the follow-up period, the investi-
gators provided all ultrasonographers with guidelines
for performing examinations. In cases of missing or
incomplete data, clarification with investigators was
obtained. Duplex ultrasonography was undertaken in
all patients preoperatively to assess the extent of
venous disease. The mean pre-operative maximum
vein diameter was 7.7 mm (range 3–17.4 mm) in the
supine position. Reflux was assessed by response to a
Valsalva manoeuvre in a reverse Trendelenburg
position or with manual limb compression and release
with the patient in a standing position. The mean
duration of reflux was 3.8 s (range 0.5–30 s). Limbs
with significant saphenous vein tortuosity which
would impede catheter advancement or with an
aneurysmal vein segment were not enrolled in the
study.
Among 330 limbs treated, 323 (97.9%) were great
saphenous veins (GSV) and seven (2.1%) were small
saphenous veins (SSV) or a saphenous tributary. For
the GSV, the location of vein treatment was limited to
the thigh and just below the knee in 268 (81.2%) limbs,
below the knee only in eight (2.4%) limbs and the
entire GSV in 47 (14.2%) limbs. The CEAP clinical class
preoperatively was C0: 2, C1: 11, C2: 236, C3: 24, C4: 47,
C5: 5 and C6: 4. The two limbs classified as C0 both
had preoperative leg pain and fatigue. In one
additional limb with leg fatigue and oedema, the
pre-treatment CEAP clinical classification was not
recorded on the data collection form.
All cases were treated with RF endovenous vein
obliteration without high ligation of the saphenofe-
moral junction (SFJ) or saphenopopliteal junctionEur J Vasc Endovasc Surg Vol 29, April 2005(SPJ). Adjunctive procedures associated at the time
of treatment included phlebectomy of the varicose
veins in 60% of the cases and sclerotherapy in 7% of
the cases.
Patients were treated using the Closurew system
(VNUS Medical Technologies, San Jose, CA). The
procedures usually were performed under general
anaesthesia although local anaesthesia (tumescent or
regional) was used in some instances. The Closure
catheter was passed pro-grade through a sheath after
percutaneous sheath insertion, or through a small skin
cut-down. The saphenous vein was catheterised either
in the ankle region or just below the knee. The catheter
connected to a saline infusion and to a radiofrequency
generator, was advanced as far as the proximal part of
the vein segment to be treated. Expandable bipolar
electrodes at the end of the catheter were deployed by
the operator. Once the catheter position was confirmed
(using ultrasound or fluoroscopy), a near bloodless
field in the vein to be treated was created by wrapping
the limb with an Esmarch bandage and placing the
patient in the Trendelenburg position. Tumescent
anaesthetic solution was not routinely injected around
the saphenous vein before treatment in this series.
Each centre adhered to its own standard treatment
protocol. The RF generator was turned on and the
temperature at the electrode/vein wall interface was
maintained at 85 8C via a feedback loop. The catheter
was gradually withdrawn at a pullback rate of
approximately two to three cm/min over the entire
length of the vein to be treated.
Colour duplex ultrasound scans and clinical exam-
inations were performed before treatment and at
regular intervals postoperatively including 1, 2 and 3
years.
Efficacy of vein obliteration was categorised as
follows:Totally occluded (TO) veins were defined as those
with no evidence of flow.
Partially occluded (PO) veins were defined as less
than or equal to 5 cm segment of flow within the SFJ
or an otherwise occluded vein trunk.
Inefficiently occluded (IO) veins were defined as
greater than 5 cm of flow in any treated vein
segment.
Reflux was defined as any evidence of reverse flow
for more than 0.5 s in any treated vein segment or at
the level of SFJ or SPJ.
Clinical assessment included a symptom severity
scoring classification and varicose vein assessment.
Varicose veins were defined as any visible abnormally
dilated, tortuous vein. For symptom severity scoring,
Multicentre 3-year Results with VNUS Closure 435limb pain, fatigue and oedema were each ranked as
absent (0), moderate (1), or severe (2). A limb’s total
score ranged from zero (asymptomatic) to six (pain,
fatigue and oedema all present and severe). The scores
were established by the surgeon assessing the patient
who recorded his findings in the clinical notes.
Data collection is ongoing and this paper includes
follow-up data through September 2002, including late
receipt of data not previously reported.Statistical Analysis
Continuous variables are presented as mean and
range. Statistical comparisons were performed using
Fisher’s Exact Probability Test or Student’s t-test
where appropriate. Differences were considered sig-
nificant at the p!0.05 level.Results
Follow-up data were available on 252 limbs from 23
centres at 1 year, 148 limbs from 17 centres at 2 years,
and 68 limbs from eight centres at 3 years (global
cohort). Among the 68 limbs with assessment at 3
years, data was available on 65/68 limbs at 1-year
follow-up and 58/68 limbs at 2-year follow-up (sub-
cohort). This sub-group was analysed independently
in addition to the global cohort to evaluate how
representative this was of the global cohort results.Efficacy of obliteration
Table 1 shows the assessments of efficacy of the global
cohort and the sub-cohort. No significant differences
were observed between the two cohorts (PO0.05). In
brief, the reflux free rates remained unchanged over
the 3 years following endovenous RF obliteration.
Table 2 summarizes the occlusion categorizations of
the global cohort at each yearly follow-up. In limbs
with partially or inefficiently occluded veins, reflux
was observed in eight PO limbs and 21 IO limbs at 1
year, 2 PO and 16 IO limbs at 2 years and five IO limbs
at 3 years.Table 1. Absence of reflux at yearly intervals—comparative summary
Follow-up duration
1 year 2 years
n % n
Absence of reflux
Global cohort 223/252 88.5 130/148
Sub-cohort 61/65 94 52/58Statistical comparisons of each of the three groups
between 1, 2 and 3 years demonstrated a significant
increase in the PO rate at 1 and 3 years (P!0.01) and
between 2 and 3 years (P!0.05).
As shown in Table 3, at 1 year the average length of
the open segment was 2.6 and 23.8 cm for the PO and
IO groups, respectively. At 3 years the average length
of the open segment was 2.3 and 20 cm for the PO and
IO groups, respectively. There was no clear change
during the follow-up period.
The length of patent saphenous vein was analysed
in the sub-group using identical criteria to those for the
whole group. Table 4 summarises the results. The size
of the PO group increased from 2 to 12 patients over
the follow-up period, whereas the size of the IO group
remained small and constant. The increase in numbers
in the PO group was drawn from the TO group which
decreased to 75% after 3 years. These changes reach
statistical significance.Clinical assessment
Fig. 1 shows the clinical assessment with regard to the
presence of limb pain, fatigue or oedema during the
follow-up period in comparison with the pre-operat-
ive status. In constructing this graph any limb with a
score of more than zero was considered to have
symptoms, irrespective of the size of the score. From
this analysis the percentage of patients with each
symptom was calculated for each time point. The
graph does not reflect that far fewer patients were
available for analysis at the later time points.
The maximum CEAP clinical class 0 or 1 (no sign of
venous disease or spider veins) consisted of 3.9% of
the limbs before treatment and improved to 82.9, 83.1
and 86.8% at 1, 2 and 3 years, respectively.
In order to examine the influence of partial
occlusion on the clinical assessment results, the mean
symptom severity score between the TO and PO
groups was analysed. No statistically significant
difference was found between the two groups at either
2 or 3 years. The mean symptom severity scores at 1
year were 0.06 for the TO and zero for the PO group
(P!0.05). There was also no significant difference
between the TO and PO groups on the number of3 years
% n %
87.8 60/68 88
90 60/68 88
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Table 2. Efficacy of obliteration outcomes at yearly intervals
Follow-up duration
1 year, nZ252 2 years, nZ148 3 years, nZ68
TO 204 (81.0%) 119 (80.4%) 51 (75%)
PO 16 (6.3%) 11 (7.4%) 12 (18%)
IO 32 (13%) 18 (12%) 5 (7.4%)
TO, totally occluded; PO, partially occluded; IO, inefficiently occluded.
Ph. Nicolini and The Closure Group436symptom free limbs at 2 (PZ1.0) and 3 (PZ0.09) years
by Fisher’s exact test. Comparisons at 2 and 3 years
between the mean symptom severity scores of the
combined TO and PO group versus the IO group
demonstrated no statistically significant difference at
either time interval. The results suggest that the
occluded length of the treated vein does not predict
the clinical symptom improvement (Table 5).
The physicians’ assessment of the presence of
varicose veins at each visit is summarised in Table 6
with the results categorised according to completeness
of vein occlusion at follow-up. Statistical comparison
between groups demonstrated significant differences
between the TO and the IO (P!0.0001) groups,
and between the combined TO and PO cohort versus
the IO group (P!0.0001), at 1 and 2 year follow-up. No
statistical difference was found between the TO and
PO groups at any time point.
The most frequent adjunctive procedure performed
(either concurrent with the RF obliteration treatment
or during the follow-up period) was stab avulsion of
varices. Out of the 330 treated limbs, 201 limbs
received avulsion phlebectomy at least once (includ-
ing at the time of RF treatment). During follow-up no
difference was found in the symptom severity score or
in the number of asymptomatic limbs between those
patients undergoing adjunctive phlebectomy and
those who received no additional treatment. Neither
did the age of the patient nor the diameter of the vein
before treatment influence the outcome as assessed
clinically or by duplex ultrasonography.
Complications which occurred following treatment
and shortly afterward have been described else-
where.2–5 Haematoma, infection, and superficialTable 3. Average length of the open segments (cm) at each yearly int
Follow-up duration
1 year 2 years
TO 0 0
PO 2.6 (1.0–5.0) 1.3
Reflux free 2.6 (1.0–5.0) 0.9
Reflux 2.7 (1.0–5.0) 3.5
IO 23.8 (5.5–80) 20.6
Reflux free 17.5 (5.5–40) 12.3
Reflux 28.1 (8.0–80) 21.8
TO, totally occluded; PO, partially occluded; IO, inefficiently occluded
* nZ1.
Eur J Vasc Endovasc Surg Vol 29, April 2005venous thrombosis were absent in all cases at 1, 2
and 3 year follow-up visits. Paraesthesia, described
more appropriately as alteration of local sensitivity,
was not observed in any of the limbs examined at the
3-year follow up. At 1 year, the incidence was 2.5% for
limbs in which treatments were limited to the thigh
and just below the knee (AK) and 7.4% for limbs with
treatments extending to the ankle (BK). At 2 years, the
incidence was 4.3% for AK treatments and 9.7% for BK
treatments. At 3 years, paraesthesia was absent in both
groups.Discussion
Primary superficial venous insufficiency has been
treated traditionally by vein stripping with sapheno-
femoral ligation. Duplex ultrasound examination has
shown persistence of reflux in the treated veins (either
stable or progressive) in 9–29% of the cases at 1 year, in
13–40% at 2 years postoperatively7–9 and 15% of
treated veins at 3 years.10
In the present study, all the endovenous saphenous
vein RF obliteration procedures were performed
without sapheno-femoral ligation. Venous reflux
demonstrated by duplex ultrasonography was present
in 11–12% of treated veins at each of the follow-up
intervals. The patients who presented with IO at 1 year
follow-up remained a small and constant number
during the observation period. These probably reflect
early treatment failures and do not arise later on. We
can probably conclude from this that veins closed by
RF ablation do not recanalise after 1 year. There was no
statistically significant difference between the TO anderval
3 years
0
(0.1–4.0) 2.3 (0.5–5.0)
(0.1–2.0) 2.1 (0.5–5.0)
(3.0–4.0) 2.7 (2.0–3.0)
(6.0–55) 20 (20)*
(9.5–15) – –
(6.0–55) 20 (20)
.
Table 4. Efficacy of saphenous obliteration in the sub-group
Follow-up duration
1 year, nZ65 2 years, nZ58 3 years, nZ68
TO 59* (90.8%) 48 (82.8%) 51* (75.0%)
PO 2† (3.1%) 6 (10.3%) 12† (17.6%)
IO 4 (6.2%) 4 (6.9%) 5 (7.4%)
TO, totally occluded; PO, partially occluded; IO, inefficiently occluded.
* p!0.05.
† p!0.01 (Fisher’s exact test).
Multicentre 3-year Results with VNUS Closure 437PO categories with respect to the symptom severity
score, the number of symptom free limbs, or the
varicose vein absence rates at any follow-up time point
(with the exception that the mean symptom severity
scores of 0.06 for the TO versus zero for the PO group
at 1 year). These results suggest that PO (a 5 cm or less
segment of open vein) does not result in the develop-
ment of symptoms.
Varicose veins were present in 10–13% of the whole
group at the three follow-up intervals. In comparison,
Jones reported absence of varices in 85.5% of the cases
at 1 year and 75% of the cases at 2 years after high
ligation and GSV stripping.9 Varicose vein recurrence
rates were associated with the IO status, confirming
that technical failure of the treatment is an adverse
factor affecting outcome as might be expected.
However, we found no difference in outcome between
the TO and the PO groups. Limbs with the outcome of
partial occlusion commonly showed absence reflux on
ultrasound. The remaining segment of vein did not
reflux or contribute in any significant way to the
recurrence of varices.
Neovascularisation, which is currently the subject
of considerable discussion and a consensus statement,
is for some authors the principal cause of post surgical
recurrence, assuming that the basic procedure has
been properly performed.9 Neovascularisation was
identified by duplex ultrasound after 2 years in 45%
(24 out of 53) of the cases following conventionalFig. 1. Clinical assessment prior to treatment and at yearly
intervals. Percentage of patients with any symptom at each
follow-up interval.saphenous ligation and stripping operations.9 One
year data reported by De Maeseneer suggest that this
process promotes the development of recurrent
varicose veins.11 In our series, no evidence of
neovascularisation was found, suggesting that this
endovenous treatment may avoid this complication
associated with groin incision and vein resection.
As the technique of RF obliteration of saphenous
vein reflux became more widely adopted, an idea
emerged suggesting that concurrent stab avulsion of
varices need not be done. The rationale was that
phlebectomies may not be needed at all in some cases.
Once the truncal saphenous reflux has been abolished
and venous hypertension removed, varices diminish
greatly in size minimising their clinical significance.
This strategy has not been evaluated in any clinical
trial. In our study, comparisons of symptom scores,
presence of symptoms and presence of visible varices
were compared between the group of ‘no phlebect-
omy’ patients (no phlebectomies performed at the
original treatment or at any point the follow-up) and
the rest of the patients at 1, 2 and 3 years. No
statistically significant differences were found.
Two further parameters, patient age and vein
diameter prior to treatment, were evaluated to assess
their effect on outcome. It might be expected that these
might influence the results of treatment. Large veins
may be less effectively treated by RF obliteration. In
elderly patients possible alterations of the collagen
fibrils’ response due to the age of the patient might
limit the success of treatment. Neither patient age nor
vein diameter was found to affect the clinical or
ultrasound assessed outcome.
The authors acknowledge that only a limited group
of patients underwent examination at the 3 year
follow-up interval representing 27% of the original
group. This may have led to patients with more
troublesome veins presenting at the longer review
intervals or perhaps those with recurrent veins
attended other clinics for treatment. We accept that
this allows for some uncertainty in our data. Long-
term registry studies have to take into consideration
the lack of follow-up data from some of the patients at
each follow-up opportunity. In order to verify theEur J Vasc Endovasc Surg Vol 29, April 2005
Table 5. Statistical significance of the symptom severity score between the sub-groups with total, partial and inefficiently occluded veins
TO PO TO and PO IO
Severity score-mean at 1
year
ns ns
Severity score-mean at 2
years
ns ns
Severity score-mean at 3
years
ns ns
Symptom free limbs at 1
year
ns
Symptom free limbs at 2
years
ns
Symptom free limbs at 3
years
ns
ns, not statistically significant (Fisher’s Exact Probability Test).
Ph. Nicolini and The Closure Group438representative ness of the most recent data, a longi-
tudinal comparison at yearly intervals of haemo-
dynamic findings for a sub-group with the 3-year
follow-up data available was performed in this study.
The results from this sub-group were comparable to
those of the global cohort, confirming that the outcome
in the whole cohort reasonably reflected the outcome
of treatment.
In conclusion, following temperature controlled
radiofrequency saphenous vein obliteration, the reflux
free rates in the treated veins remained unchanged
over a 3 year follow-up period. There is no difference
in clinical outcomes between the TO and the PO limbs,
suggesting that clinical effectiveness of this technique
is maintained where a small segment of patent
saphenous vein persists. In the IO group with greater
than a 5 cm open segment in treated veins there is an
increased risk of recurrence and has to be monitored in
the long term follow-up.Acknowledgements
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Technologies, for his assistance.Table 6. Varicose veins assessment at each yearly follow-up interval
Follow-up duration
1 year 2 years
n % n
Outcome NZ252 NZ148
TO 204 81.0 119
Varicose veins
absent
193 94.6 112
PO 16 6.3 11
Varicose veins
absent
14 87.5 9
IO 32 12.7 18
Varicose veins
absent
20 62.5 8
Total 227 90.1 129
TO, totally occluded; PO, partially occluded; IO, inefficiently occluded
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